BAP1 Loss Defines a Pathologically Aggressive Subgroup of Clear Cell Renal Cell Carcinoma

被引：0
|
作者：
Kapur, P. [1 ]
Christie, A. [1 ]
Pena-Llopis, S. [1 ]
Margulis, V. [1 ]
Lotan, Y. [1 ]
Xie, X-J [1 ]
Brugarolas, J. [1 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
926
引用
收藏
页码：223A / 223A
页数：1
相关论文
共 50 条
  • [31] Immunohistochemical Comparison of BAP1 Immunoexpression Status between Needle Biopsies and Nephrectomies in Clear Cell Renal Cell Carcinoma
    Friedman, Paul
    Homayoun, Farrah
    Margulis, Vitaly
    Cadeddu, Jeffrey
    Rakheja, Dinesh
    Brugarolas, James
    Kapur, Payal
    MODERN PATHOLOGY, 2016, 29 : 229A - 230A
  • [32] Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico
    Jin, Shengming
    Wu, Junlong
    Zhu, Yao
    Gu, Weijie
    Wan, Fangning
    Xiao, Wenjun
    Dai, Bo
    Zhang, Hailiang
    Shi, Guohai
    Shen, Yijun
    Zhu, Yiping
    Ye, Dingwei
    JOURNAL OF CANCER, 2018, 9 (22): : 4108 - 4116
  • [33] Immunohistochemical Comparison of BAP1 Immunoexpression Status between Needle Biopsies and Nephrectomies in Clear Cell Renal Cell Carcinoma
    Friedman, Paul
    Homayoun, Farrah
    Margulis, Vitaly
    Cadeddu, Jeffrey
    Rakheja, Dinesh
    Brugarolas, James
    Kapur, Payal
    LABORATORY INVESTIGATION, 2016, 96 : 229A - 230A
  • [34] ADVERSE OUTCOMES IN CLEAR CELL RENAL CELL CARCINOMA WITH MUTATIONS OF EPIGENETIC REGULATORS BAP1 AND SETD2
    Hakimi, A. Ari
    Ostrovnaya, Irina
    Reva, Boris
    Schultz, Nikolaus
    Chen, Ying-Bei
    Gonen, Mithat
    Liu, Han
    Takeda, Shugaku
    Tickoo, Satish K.
    Voss, Martin H.
    Cheng, Emily H.
    Reuter, Victor E.
    Motzer, Robert J.
    Russo, Paul
    Hsieh, James J.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E438 - E438
  • [35] The critical role of BAP1 mutation in the prognosis and treatment selection of kidney renal clear cell carcinoma
    Tan, Guobin
    Xuan, Zijun
    Li, Zhiqin
    Huang, Shuitong
    Chen, Guangming
    Wu, Yonglu
    Chen, Xianxi
    Liang, Zhijin
    Wu, Aiming
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (04) : 1725 - 1734
  • [36] Concomitant Loss of PBRM1 and BAP1 Protein Expression is an Important Prognostic Event in Early Stages of Clear Cell Renal Cell Carcinoma.
    da Cunha, Isabela W.
    da Costa, Walter H.
    Fares, Aline F.
    Bezerra, Stephania M.
    Schultz, Luciana
    Guimaraes, Gustavo C.
    Zequi, Stenio C.
    MODERN PATHOLOGY, 2018, 31 : 336 - 336
  • [37] Clinicopathologic Features of Clear Cell Renal Cell Carcinomas with Loss of Nuclear BAP1 Expression: A Multi-Institutional Study
    Czaja, Rebecca
    Tripathy, Anusmita
    Zalles, Nicole
    Williamson, Sean
    Antic, Tatjana
    Gallan, Alexander
    LABORATORY INVESTIGATION, 2023, 103 (03) : S703 - S704
  • [38] PBRM1, SETD2 and BAP1 — the trinity of 3p in clear cell renal cell carcinoma
    Joseph Walton
    Keith Lawson
    Panagiotis Prinos
    Antonio Finelli
    Cheryl Arrowsmith
    Laurie Ailles
    Nature Reviews Urology, 2023, 20 : 96 - 115
  • [39] PBRM1 and BAP1 as Novel Targets for Renal Cell Carcinoma
    Brugarolas, James
    CANCER JOURNAL, 2013, 19 (04): : 324 - 332
  • [40] BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor
    Jeanette E. Eckel-Passow
    Daniel J. Serie
    John C. Cheville
    Thai H. Ho
    Payal Kapur
    James Brugarolas
    R. Houston Thompson
    Bradley C. Leibovich
    Eugene D. Kwon
    Richard W. Joseph
    Alexander S. Parker
    BMC Urology, 17
12345